Thanks to the improvement in transplant skills and newly developed immunosuppressive agents, rejections after solid organ transplants (SOTs) have been greatly reduced and SOTs are more likely to succeed. In recent years, invasive fungal diseases (IFDs) have been increasing after SOTs and have become a major reason for recipient death with normal function of transplants, which poses a great threat to SOTs and has drawn great concern from physicians. Success management of IFD depends on early diagnosis and timely treatment. Currently available reports mainly focus on case-reports or retrospective analyses. This paper reviews the risk factors, prevalence, diagnosis and management of IFDs in SOT recipients.